Taylor & Francis Group
IMT-2021-0057.docx (15.32 kB)

Supplementary Table – The Optimal Subsequent Treatments for Patients with Hepatocellular Carcinoma Resistant to Anti-PD-1 Treatments

Download (15.32 kB)
posted on 2021-11-11, 09:42 authored by Xuqi Sun, Ziliang Yang, Yuhao Tang, Sihan Mao, Peiyao Xiong, Juncheng Wang, Jinbin Chen, Yaojun Zhang, Minshan Chen, Li Xu
Supplementary table 1. Comparison of clinical characteristics between patients with and without progressive disease (PD)